🎉 A Remarkable Month for our Immunoendocrinology Team! 🎉
We are incredibly proud of our team's achievements this month. Not one, not two, but three high-impact publications came out of our collective efforts.
Highlights from this month:
Renate Akkerman, in collaboration with the team of Marthe Walvoort published:
Exopolysaccharides from Bifidobacterium longum subsp. infantis and Bifidobacterium adolescentis modulate Toll-like receptor signaling.
This study, published in Carbohydrate Polymers, demonstrates how exopolysaccharides from Bifidobacteria have species-specific effects on immunity, positioning them as key effector molecules of these health-regulating gut microbes.
Luis Silva Lagos, alongside with Henk Schols, Cynthia Klostermann and Gabriel Lopez, authored:
Immunostimulatory effects of isomalto/malto-polysaccharides via TLR2 and TLR4 in preventing doxycycline-induced cytokine loss.
Also published in Carbohydrate Polymers, this study highlights the potential of IMMP to counteract the immune-dampening effects of antibiotics like Doxycycline, advancing the fight against antibiotic overuse and resilience after antibiotic use.
Paul de Vos, together with the ILSI Europe team, published:
Prebiotics in food and dietary supplements: a roadmap to EU health claims.
This impactful paper, featured in Gut Microbes, provides a comprehensive roadmap for leveraging prebiotics in food and supplements to support EU health claims.
These publications are a testament to the dedication, collaboration, and innovative spirit of our #immunoendocrinology team.
👏 Huge congratulations to everyone involved—your work inspires us all!